Debora de Melo Gagliato (Débora Gagliato, Debora Gagliato)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 8

Top Topics

Tyrosine Kinase

Metastatic Breast Cancer

Top Venues

Oncology and therapy

Journal of medical case reports

European journal of breast health

This page only lists publications with an associated author ORCID identifier.

Publications

Debora de Melo Gagliato, Tomás Reinert, Cláudio Rocha, Monique Celeste Tavares, Sâmio Pimentel, William Fuzita, Márcia Araújo, Danielli Matias, Sabina Aleixo, Bruno França, Érida Magaton, Natália Brito, Ana Carolina Ferreira Cardoso, Vivienne Carduz Castilho
Real-World Study of Adjuvant Biosimilar Trastuzumab-dkst for HER2-Positive Breast Cancer Treatment in a Brazilian Population. Oncology and therapy 12 (3) (2024)
Debora de Melo Gagliato, Tomás Reinert, Cláudio Rocha, Monique Celeste Tavares, Sâmio Pimentel, William Fuzita, Márcia Araújo, Danielli Matias, Sabina Aleixo, Bruno França, Érida Magaton, Natália Brito, Ana Carolina Ferreira Cardoso, Vivienne Carduz Castilho
Real-World Study of Adjuvant Biosimilar Trastuzumab-dkst for HER2-Positive Breast Cancer Treatment in a Brazilian Population. Oncology and therapy 12 (3) (2024)
Debora de Melo Gagliato, Tomás Reinert, Cláudio Rocha, Monique Celeste Tavares, Sâmio Pimentel, William Fuzita, Márcia Araújo, Danielli Matias, Sabina Aleixo, Bruno França, Érida Magaton, Natália Brito, Ana Carolina Ferreira Cardoso, Vivienne Carduz Castilho
Real-World Study of Adjuvant Biosimilar Trastuzumab-dkst for HER2-Positive Breast Cancer Treatment in a Brazilian Population. Oncology and therapy (2024)
Debora de Melo Gagliato, Tomás Reinert, Cláudio Rocha, Monique Celeste Tavares, Sâmio Pimentel, William Fuzita, Márcia Araújo, Danielli Matias, Sabina Aleixo, Bruno França, Érida Magaton, Natália Brito, Ana Carolina Ferreira Cardoso, Vivienne Carduz Castilho
Real-World Study of Adjuvant Biosimilar Trastuzumab-dkst for HER2-Positive Breast Cancer Treatment in a Brazilian Population. Oncology and therapy 12 (3) (2024)
Priscila de Medeiros Souza, Filomena Marília Henriques Carvalho, Fernando Nalesso Aguiar, Debora de Melo Gagliato, Alfredo Carlos Simões Dornellas de Barros
Association Between GATA3 and Histopathological and Immunohistochemical Parameters in Early-Infiltrating Breast Carcinomas. European journal of breast health 18 (3) (2022)
Debora de Melo Gagliato, Antonio C Buzaid, Jose Manuel Perez-Garcia, Antonio Llombart, Javier Cortes
CDK4/6 Inhibitors in Hormone Receptor-Positive Metastatic Breast Cancer: Current Practice and Knowledge. Cancers 12 (9) (2020)
Debora de Melo Gagliato, Xiudong Lei, Sharon H Giordano, Vicente Valero, Carlos H Barcenas, Gabriel N Hortobagyi, Mariana Chavez-MacGregor
Impact of Delayed Neoadjuvant Systemic Chemotherapy on Overall Survival Among Patients with Breast Cancer. The oncologist 25 (9) (2020)
Debora de Melo Gagliato, Rudinei Diogo Marques Linck, Regis Otaviano Franca Bezerra, Mirela Souto, Gabriel Lima Lopes, Glauco Baiocchi, Max Senna Mano
An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report. Journal of medical case reports 10 (2016)